Cargando…

Correction: Monitoring Toxicity Associated with Parenteral Sodium Stibogluconate in the Day-Case Management of Returned Travellers with New World Cutaneous Leishmaniasis

Detalles Bibliográficos
Autores principales:	Wise, Emily S., Armstrong, Margaret S., Watson, Julie, Lockwood, Diana N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3466327/ http://dx.doi.org/10.1371/annotation/15ab4f39-31e7-40bc-9b15-6e90a612b49a

Ejemplares similares

Monitoring Toxicity Associated with Parenteral Sodium Stibogluconate in the Day-Case Management of Returned Travellers with New World Cutaneous Leishmaniasi
por: Wise, Emily S., et al.
Publicado: (2012)

Treatment failure to sodium stibogluconate in cutaneous leishmaniasis: A challenge to infection control and disease elimination
por: Silva, Hermali, et al.
Publicado: (2021)

The Efficacy and Safety of Intralesional Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis in Children under the Age of Two Years
por: Hussein, Nawfal R, et al.
Publicado: (2020)

Cutaneous leishmaniasis in a returned traveler
por: Kundu, Rupayan, et al.
Publicado: (2022)

Effectiveness of intralesional sodium stibogluconate for the treatment of localized cutaneous leishmaniasis at Boru Meda general hospital, Amhara, Ethiopia: Pragmatic trial
por: Tilahun Zewdu, Feleke, et al.
Publicado: (2022)

Treatment of Cutaneous Leishmaniasis with Sodium Stibogluconate and Allopurinol in a Routine Setting in Ethiopia: Clinical and Patient-Reported Outcomes and Operational Challenges
por: van Henten, Saskia, et al.
Publicado: (2023)

A Comparison of the Effectiveness of Sodium Stibogluconate Monotherapy to Sodium Stibogluconate and Paromomycin Combination for the Treatment of Severe Post Kala Azar Dermal Leishmaniasis in South Sudan – A Retrospective Cohort Study
por: Abongomera, Charles, et al.
Publicado: (2016)

Evaluating the Efficacy of Combined Intralesional Sodium Stibogluconate Plus Topical Imiquimod on Healing and Risk of Scarring of Cutaneous Leishmaniasis: A Case-Control Study
por: Dhaher, Samer A, et al.
Publicado: (2022)

Sodium stibogluconate loaded nano-deformable liposomes for topical treatment of leishmaniasis: macrophage as a target cell
por: Dar, M. Junaid, et al.
Publicado: (2018)

Cutaneous leishmaniasis and health-related quality of life in returning travellers to the UK
por: Peleva, Emilia, et al.
Publicado: (2020)

LEISHMANIASIS OF THE LIP DIAGNOSED BY LYMPH NODE ASPIRATION AND TREATED WITH A COMBINATION OF ORAL KETACONAZOLE AND INTRALESIONAL SODIUM STIBOGLUCONATE
por: Vasudevan, Biju, et al.
Publicado: (2011)

High Parasitological Failure Rate of Visceral Leishmaniasis to Sodium Stibogluconate among HIV Co-infected Adults in Ethiopia
por: Diro, Ermias, et al.
Publicado: (2014)

Sodium Stibogluconate (SSG) & Paromomycin Combination Compared to SSG for Visceral Leishmaniasis in East Africa: A Randomised Controlled Trial
por: Musa, Ahmed, et al.
Publicado: (2012)

Leishmania major Cutaneous Leishmaniasis in 3 Travelers Returning from Israel to the Netherlands
por: Kuilder, Justin S., et al.
Publicado: (2016)

Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme
por: Kimutai, Robert, et al.
Publicado: (2017)

Transcriptional responses of Leishmania (Leishmania) amazonensis in the presence of trivalent sodium stibogluconate
por: Patino, Luz H., et al.
Publicado: (2019)

Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial
por: Wasunna, Monique, et al.
Publicado: (2016)

A Randomized Controlled Trial of Local Heat Therapy Versus Intravenous Sodium Stibogluconate for the Treatment of Cutaneous Leishmania major Infection
por: Aronson, Naomi E., et al.
Publicado: (2010)

Mucosal Leishmaniasis in Travelers with Leishmania braziliensis Complex Returning to Israel
por: Solomon, Michal, et al.
Publicado: (2019)

Cutaneous Myiasis in Traveler Returning from Ethiopia
por: Hannam, Paul, et al.
Publicado: (2011)

Visceral Leishmaniasis in Traveler to Guyana Caused by Leishmania siamensis, London, UK
por: Polley, Spencer D., et al.
Publicado: (2018)

Assessment of serum amylase, lipase and associated factors among patients with visceral leishmaniasis treated with sodium stibogluconate/paromomycin at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia
por: Mengstie, Tiget Ayelgn, et al.
Publicado: (2021)

Species-Directed Therapy for Leishmaniasis in Returning Travellers: A Comprehensive Guide
por: Hodiamont, Caspar J., et al.
Publicado: (2014)

Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea
por: Guery, Romain, et al.
Publicado: (2017)

Safety and Efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial
por: Omollo, Raymond, et al.
Publicado: (2011)

Cutaneous leishmaniasis caused by Leishmania (Viannia) panamensis in 2 travelers
por: Achtman, Jordan C., et al.
Publicado: (2016)

Efficacy and safety of a combined treatment of sodium stibogluconate at 20mg/kg/day with upper maximum daily dose limit of 850mg and Paromomycin 15mg/kg/day in HIV negative visceral leishmaniasis patients. A retrospective study, northwest Ethiopia
por: Tamiru, Aschalew, et al.
Publicado: (2021)

False-positive rapid diagnostic test for malaria in new world cutaneous leishmaniasis: a tale of two travelers
por: Unterborn, Rebecca, et al.
Publicado: (2022)

Leg ulceration due to cutaneous melioidosis in a returning traveller
por: Stavrou, Christiana, et al.
Publicado: (2021)

Cutaneous Leishmaniasis in a Recreational Cave Diver After Travel to México
por: Siller Jr., Alfredo, et al.
Publicado: (2021)

Leishmania (Viannia) guyanensis Causing Localized Cutaneous Leishmaniasis in a Traveler
por: Motie, Ian K, et al.
Publicado: (2022)

Self-application of aminoglycoside-based creams to treat cutaneous leishmaniasis in travelers
por: Mouri, Oussama, et al.
Publicado: (2023)

Formulation of Amphotericin B in PEGylated Liposomes for Improved Treatment of Cutaneous Leishmaniasis by Parenteral and Oral Routes
por: Ramos, Guilherme S., et al.
Publicado: (2022)

Topical paromomycin for New World cutaneous leishmaniasis
por: Sosa, Néstor, et al.
Publicado: (2019)

A cluster of cutaneous larva migrans in travellers returning from Zanzibar
por: Korzeniewski, Krzysztof
Publicado: (2021)

Therapy with Sodium Stibogluconate in Stearylamine-Bearing Liposomes Confers Cure against SSG-Resistant Leishmania donovani in BALB/c Mice
por: Roychoudhury, Jayeeta, et al.
Publicado: (2011)

The Returning Traveller
por: Geddes, A.M., et al.
Publicado: (1981)

Pancytopenia due to proguanil toxicity in a returning traveller with fever
por: Jolink, Hetty, et al.
Publicado: (2010)

A rare case of visceral leishmaniasis in an immunocompetent traveler returning to the United States from Europe
por: Haque, Lamia, et al.
Publicado: (2018)

Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effects
por: Yi, Taolin, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_opihneb21c3gqilggt15i8or0k